Oncology Today with Dr Neil Love
by Dr. Neil Love
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 4 chart positions in 4 markets.
By chart position
- 🇰🇷KR · Science#1601K to 10K
- 🇸🇦SA · Science#923K to 10K
- 🇹🇷TR · Science#157500 to 3K
- 🇭🇰HK · Science#181500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.5K to 7.8K🎙 Daily cadence·398 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
5K to 26K🇰🇷38%🇸🇦38%🇹🇷12%+1 more - Active Followers
Loyal subscribers who consistently listen
1.5K to 7.8K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 33 epsHosts
Recent guests
Recent episodes
Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Jul 20, 2026
1h 29m 57s
HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy
Jul 17, 2026
46m 28s
For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress
Jul 16, 2026
1h 58m 26s
Ovarian Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Jul 15, 2026
2h 01m 19s
HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review
Jul 14, 2026
27m 32s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/20/26 | Endometrial CancerChemoimmunotherapy+3 | Dr Floor J BackesDr Brian M Slomovitz | — | — | Endometrial CancerChemoimmunotherapy+5 | — | 1h 29m 57s | ||
| 7/17/26 | HER2-positive metastatic breast cancerfirst-line therapy+5 | Prof Dr Sibylle Loibl | trastuzumab deruxtecanpertuzumab+1 | — | HER2-positivemetastatic breast cancer+6 | — | 46m 28s | ||
| 7/16/26 | Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+4 | Dr Farrukh T AwanDr Brad S Kahl+2 | CD20 x CD3 Bispecific AntibodiesPolatuzumab Vedotin+5 | — | Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+6 | — | 1h 58m 26s | ||
| 7/15/26 | Ovarian CancerPARP Inhibitors+3 | Dr Ramez N EskanderDr Ursula Matulonis+2 | — | — | Ovarian CancerPARP Inhibitors+3 | — | 2h 01m 19s | ||
| 7/14/26 | HER2-Altered Non-Small Cell Lung Cancerzongertinib+3 | Dr Mark JengDr Joshua K Sabari | zongertinib | — | HER2non-small cell lung cancer+3 | — | 27m 32s | ||
| 7/13/26 | HR-Positive Breast CancerAdjuvant Treatment+4 | Dr Harold J BursteinDr Joyce O’Shaughnessy | — | — | breast canceradjuvant therapy+4 | — | 58m 12s | ||
| 7/12/26 | endometrial cancerneoadjuvant immunotherapy+3 | Dr Floor J BackesDr Matthew A Powell | mismatch repair-deficient metastatic endometrial cancermicrosatellite instability-high endometrial cancer | — | endometrial cancerneoadjuvant immunotherapy+3 | — | 15m 08s | ||
| 7/11/26 | Non-Small Cell Lung CancerImmunotherapy+4 | Dr Jamie E Chaft | NeoADAURA | — | non-small cell lung cancerimmunotherapy+5 | — | 59m 55s | ||
| 7/10/26 | endometrial cancermolecular analyses+3 | Dr Floor J BackesDr Matthew A Powell+1 | SGOendometrial cancer | — | endometrial cancermetastatic cancer+3 | — | 11m 23s | ||
| 7/9/26 | Non-Hodgkin LymphomaAntibody-Drug Conjugates+3 | Dr Christopher FlowersDr Matthew Lunning+2 | ASCOCD79b-Targeted Antibody-Drug Conjugates+2 | — | Non-Hodgkin LymphomaCD79b+5 | — | 1h 57m 14s | ||
| 6/12/26 | renal cell carcinomaoncology+3 | Dr Thomas HutsonDr Eric A Singer+1 | Sarah Cannon Research InstituteThe Ohio State University Comprehensive Cancer Center+1 | — | renal cell carcinomaoncology+3 | — | 1h 28m 33s | ||
| 6/11/26 | breast cancermetastatic cancer+5 | Dr Sara A HurvitzDr Virginia Kaklamani | Fred Hutchinson Cancer CenterUT Health San Antonio MD Anderson Cancer Center | Seattle, WashingtonSan Antonio, Texas | metastatic breast cancerER-positive+5 | — | 58m 22s | ||
| 6/8/26 | Small Cell Lung Cancerclinical trial data+3 | Dr Christine L HannDr Jacob Sands | Johns Hopkins University School of MedicineDana-Farber Cancer Institute | Baltimore, MarylandBoston, Massachusetts | small cell lung cancerclinical trials+3 | — | 58m 47s | ||
| 6/5/26 | genitourinary cancerscirculating tumor DNA+3 | Professor Thomas Powles | Barts Cancer Institute | London, United Kingdom | genitourinary cancerscirculating tumor DNA+5 | — | 22m 38s | ||
| 6/3/26 | antibody-drug conjugatesgynecologic cancers+3 | Prof Ramez N EskanderDr Bradley J Monk+1 | UC San Diego Moores Cancer CenterFlorida Cancer Specialists & Research Institute+1 | — | antibody-drug conjugatesgynecologic cancers+3 | — | 1h 31m 15s | ||
| 6/2/26 | desmoid tumorstreatment strategies+3 | Prof Bernd Kasper | Mannheim Cancer Center | Mannheim, Germany | desmoid tumorstreatment+3 | — | 22m 50s | ||
| 5/28/26 | colorectal cancerclinical trials+3 | Dr Arvind DasariDr Anwaar Saeed | University of Texas MD Anderson Cancer CenterUPMC Hillman Cancer Center | HoustonPittsburgh | colorectal cancerclinical trials+3 | — | 58m 48s | ||
| 5/26/26 | genitourinary cancerscirculating tumor DNA+3 | Professor Thomas Powles | Barts Cancer Institute | London, United Kingdom | genitourinary cancerscirculating tumor DNA+3 | — | 29m 57s | ||
| 5/23/26 | Bruton tyrosine kinase inhibitorschronic lymphocytic leukemia+3 | Dr Jennifer R BrownProf Wojciech Jurczak | Bruton tyrosine kinasechronic lymphocytic leukemia | — | Bruton tyrosine kinasechronic lymphocytic leukemia+3 | — | 58m 42s | ||
| 5/21/26 | ovarian cancerclinical trials+4 | Prof Nicoletta ColomboDr Alexander Olawaiye+2 | European Institute of Oncology IRCCSUniversity of Pittsburgh School of Medicine+2 | — | ovarian cancerclinical trials+4 | — | 1h 28m 27s | ||
| 5/7/26 | nonmelanoma skin cancerstreatment strategies+3 | Dr Nikhil I Khushalani | Moffitt Cancer Center | Tampa, Florida | nonmelanoma skin cancertreatment strategies+3 | — | 1h 03m 49s | ||
| 5/3/26 | localized colorectal cancerclinical findings+3 | Dr Stacey A CohenDr Jenny Seligmann+1 | Fred Hutchinson Cancer CenterUniversity of Leeds+1 | — | colorectal cancerASCO+3 | — | 18m 11s | ||
| 4/30/26 | breast cancerclinical trials+3 | Dr Aditya BardiaDr Erica Mayer | University of California Los AngelesDana-Farber Cancer Institute | Boston, Massachusetts | oral SERDsbreast cancer+3 | — | 57m 18s | ||
| 4/27/26 | EGFR mutationnon-small cell lung cancer+3 | Dr Suresh S RamalingamDr Helena Yu | EGFRNon-Small Cell Lung Cancer | — | EGFR mutationnon-small cell lung cancer+3 | — | 57m 26s | ||
| 4/24/26 | immunotherapytargeted therapy+3 | Dr Jaffer AjaniDr Samuel Klempner+2 | The University of Texas MD Anderson Cancer CenterMassachusetts General Hospital+2 | — | immunotherapytargeted therapy+4 | — | 16m 54s |
Showing 25 of 25
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Chart history for Oncology Today with Dr Neil Love
Peaked at #92 in SA, currently #92 in SA.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| SA | — | #92 | #92 | — |
| TR | — | #157 | #157 | — |
| South Korea | — | #160 | #160 | — |
| HK | — | #181 | #181 | — |
Chart Positions
4 placements across 4 markets.
Chart Positions
4 placements across 4 markets.